OnKure Therapeutics, Inc. (OKUR NASDAQ) stock market data APIs
$4.1822
-0.08(-1.9%)
as of May 22, 2026
Try our APIs with
free plan!
OnKure Therapeutics, Inc. Financial Data Overview
Price chart is built with
Anychart
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
Prev. Close
4.1822
Open
4.1064
High
4.323
Low
4.0944
52 wk Range
1.91-5.38
Market Cap
164 M
Shares Outstanding
40 395 K
EPS
-1.11
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with OnKure Therapeutics, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get OnKure Therapeutics, Inc. data using free add-ons & libraries
Get OnKure Therapeutics, Inc. Fundamental Data
OnKure Therapeutics, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -61 132 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get OnKure Therapeutics, Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-06
- EPS/Forecast: -0.7425
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
OnKure Therapeutics, Inc. News
New
Biotech Stock Gainers: CODX Extends Rally, SBFM Surges, GOVX Ebola Strategy, RGNX Awaits Catalysts
(RTTNews) - Today's gainers include CODX, which rallied for the third straight day; Akari, on breakthrough clinical data in pancreatic cancer; Sunshine, following regulatory approval for its generic A...
CVS Q1 Earnings Preview: Health Services Likely to Lead Performance
CVS Health CVS is scheduled to report first-quarter 2026 results on May 6, before the market opens. The company posted adjusted earnings per share (EPS) of $1.09 in the last reported quarter, which ...
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?
Thermo Fisher Scientific TMO is set to release first-quarter 2026 results on April 23, before the market opens. In the last reported quarter, the company posted adjusted earnings per share (EPS) of...
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update
-- First patients dosed in triplet expansion arms of the PIKture-01 trial evaluatingOKI-219 in combination with fulvestrant and ribociclib, and in combination with trastuzumab and tucatinib in patient...
Get OnKure Therapeutics, Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
